ATLANTA—Results from the first large study of a vaccine for dengue fever — in 4000 Thai children — show that it is safe to use and effective — raising immunity to three out of the four “serotypes” of this mosquito-borne virus. Although these findings — announced at the American Society of Tropical Medicine and Hygiene annual meeting — show that complete protection — against all four virus types — is still not possible, Professor Jeremy Farrar of Oxford University’s Unit in Ho Chi Minh city told Peter Goodwin that expectations about the vaccine were perhaps too high, and that the results just announced are encouraging, because the risk of dengue is continually rising as more people travel around the world spreading the infection.
You may also like...
Longevity And Anti-Aging: A Minimum Income For Healthy Living 1 Nov, 2009 London School of Hygiene & Tropical Medicine Audio News – Europe’s Surge Against Cancer 7 Feb, 2008 Women Just As Likely As Men To Have Tuberculosis 16 Feb, 2010 Locating Asymptomatic Malaria In Africa — New Methods Raise Hopes For Elimination 30 Mar, 2012
- Previous story New drug looks very promising in high risk chronic lymphocytic leukaemia
- Next story Acute promyelocytic leukaemia: arsenic better than chemotherapy to combine with retinoic acid?
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014